Evidence map›Paper›PMID 11321361›Full record

ArticleInflammation2001

TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.

T Nakabayashi, K M Sakata, A Sakata, L Kong, C A Lau, J J Letterio, N Vela-Roch, N Talal, H Dang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

T NakabayashiUniversity of Texas Health Science Center at San Antonio, Department of Medicine, 78229, USA.
K M Sakata
A Sakata
L Kong
C A Lau
J J Letterio
N Vela-Roch
N Talal
H Dang
The University of Texas Health Science Center at San Antonio · USColumbia University · USNational Cancer Institute · USNational Institutes of Health · US

Funding

SJOGRENS SYNDROME SALIVARY GLAND AND APOPTOSISR01DE012203 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DANG, HOWARD · 1999 to 2001
$453k
NIDCR NIH HHS DE12203
6 · The paper itself

Abstract

The TGF-beta1(-/-) mouse is a murine model for systemic autoimmune disease. The aim of this study is to elucidate the immunological mechanism that leads to multifocal tissue inflammation and autoantibody production in TGF-beta1(-/-) mice. Heart, lung, liver, and salivary gland from TGF-beta1(-/-) were assessed for CD154 expression by RT-PCR and immunohistochemistry. Compared to wild-type littermates, CD154 expression was elevated in all tissues studied. Furthermore, IL-12 mRNA was expressed in the salivary gland and heart of TGF-beta1(-/-) mice and not in wild-type littermates. This suggests that the CD154 pathway is activated in these tissues. This shows that TGF-beta1 regulates CD154 expression leading to spontaneous IL-12 production and autoimmunity.

Indexed as

AnimalsAutoimmunityCD40 LigandImmunohistochemistryInflammationInterleukin-12LiverLungLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMyocardiumRNA, MessengerSalivary GlandsTissue DistributionCD40 LigandInterleukin-12RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID11321361
OpenAlexW178886096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.